SCNI NASDAQ
Scinai Immunotherapeutics Ltd.
1W: -14.2%
1M: -43.2%
3M: +394.8%
YTD: +82.3%
1Y: -4.3%
3Y: -84.9%
5Y: -99.4%
$1.33
+0.02 (+1.53%)
Weekly Expected Move ±34.0%
$0
$1
$1
$2
$2
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Cash Flow Trends
Operating Cash Flow
-$6M
+32.5% ▲
Capital Expenditures
$12K
+98.1% ▲
5Y CAGR: -64.6%
Free Cash Flow
-$6M
+36.7% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$3M
+68.3% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$1M | -$8M | -$6M | -$6M | $5M |
| Depreciation & Amort. | $758K | $471K | $562K | $514K | $2M |
| Stock-Based Comp. | $3M | $3M | $2M | $1M | $682K |
| Change in Working Capital | $196K | $701K | $446K | -$646K | $112K |
| Other Non-Cash Items | -$25M | -$3M | -$4M | -$4M | -$14M |
| Operating Cash Flow | -$23M | -$7M | -$7M | -$9M | -$6M |
| — Investing Activities — | |||||
| Capital Expenditures | -$2M | -$139K | -$836K | -$637K | -$12K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $61K | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$2M | -$139K | -$836K | -$637K | -$12K |
| — Financing Activities — | |||||
| Net Debt Issuance | -$386K | -$393K | $0 | $0 | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $304K | $393K | $27K | $947K | $1M |
| Financing Cash Flow | $4M | $21M | $7M | $1M | $3M |
| Net Change in Cash | -$18M | $14M | -$3M | -$9M | -$3M |
| Cash End of Period | $3M | $18M | $14M | $5M | $2M |
| Free Cash Flow | -$24M | -$8M | -$8M | -$10M | -$6M |